1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Global Proton Therapy Market Report: 2015 Edition

Global Proton Therapy Market Report: 2015 Edition

  • January 2016
  • -
  • Koncept Analytics
  • -
  • 61 pages

Radiation describes the way energy moves from one place to another. One of the top technological developments in the field of radiotherapy has allowed for the evolution of proton therapy. Proton therapy, also called proton beam therapy, is a type of radiation treatment that uses protons rather than x-rays to treat cancer. It is a highly precise method of radiotherapy which is suitable for all patients regardless of age, mainly depending on diagnosis. A proton is a positively charged particle. Technological upgradations like rotational gantries, higher energies and larger fields have expanded the application of proton therapy to almost every site of the human body .

Proton therapy market is mainly centred in the Americas, more specifically in the North American region. However, since last few years, it has been observed that the technology is now being adopted at a fast pace by medical specialists of the European and Asian regions. The technology around proton therapy has also made inroads in various other corners of the world all because of the increasing financial strength and interest of governments in its advancement.

Some of the factors driving the growth of proton therapy and thus radiation therapy are increasing number of cancer cases worldwide, growing preference for non-invasive procedures and technological innovations. Other factors like ageing population also promote the use of proton therapy equipments. Proton therapy treatment centers involve huge investments in terms of finance, location as well as experienced professional with hands-on-experience of this technology. Cutting edge technologies like pencil beam scanning hold the potential to elevate the ability to treat the highly complex tumors, while leaving healthy tissue and critical structures untouched. This particular technology is used with proton therapy and thus, many new proton centers are adapting it worldwide.

This report assesses the proton therapy market and associated terms in terms of both market volume and market value. The top companies having a vicious competition with each other and dominating the industry are- IBA Inc, Varian Medical systems, Elekta, and Hitachi Ltd. These players are being profiled in the report along with their key financials and strategies for growth.

Table Of Contents

Global Proton Therapy Market Report: 2015 Edition
1. Radiation Therapy

1.1 Classification

1.1.1 External Beam Radiation Therapy
1.1.2 Internal Radiation Therapy or Brachytherapy
1.1.3 Other Treatment Options

1.2 Market Analysis

1.2.1 Global Market
-Market Value
-Market Segments

1.2.2 Regional Markets
-Regional Share
-LINAC Volume

2. Proton Therapy

2.1 Applications

2.1.1 On the Basis of Cancer Site
2.1.2 On the Basis of Dosage

2.2 Technological Substitutes Comparatives

2.2.1 Proton Therapy and X-ray Radiation
2.2.2 Proton Therapy and Surgery

2.3 Treatment Devices
2.4 Global Market Analysis
-Market Value
-Market Segmentation

2.4.1 On the Basis of Patient Volume
-Annual Volume
-Cumulative Volume
-Forecasted Volume

2.4.2 On the Basis of Installation Base
-Annual Volume
-Cumulative Volume
-Forecasted Volume
-Cost per Room

2.4.3 On the Basis of Therapy Centers
2.4.4 On the Basis of Clinical Studies and Publications

2.5 Regional Market Analysis

2.5.1 On the Basis of Patient Volume
-North America
-Europe
-Asia

2.5.2 On the Basis of Installation Base
-North America
-Europe
-Asia

3. Market Dynamics

3.1 Growth Drivers

3.1.1 Increasing Cancer Incidences
3.1.2 Preference for Noninvasive Procedures
3.1.3 Rising Ageing Population
3.1.4 Technological Innovations

3.2 Challenges

3.2.1 High Installation Cost
3.2.2 Competitive Technologies
3.2.3 Shortages in Low Middle Income Countries (LMIC)
3.2.4 Cost Pressures for Prostate Cancers
3.2.5 Reimbursement Rates
3.2.6 Stringent Regulations

3.3 Key Trends

3.3.1. Technological Innovation
3.3.2. Pencil Beam Scanning

4. Competitive Landscape
-Center Sold Share
-Rooms Sold Share

5. Company Profiles

5.1 Varian Medical Systems Inc.

5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies

5.2 Elekta

5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies

5.3 IBA Inc.

5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies

5.4 Hitachi, Ltd.

5.4.1 Business Overview
5.4.2 Financial Overview
5.4.3 Business Strategies

List of Charts

Cancer Therapies Classification
Global Radiation Therapy Equipment Market (2009-2014)
Global Radiation Therapy Equipment Share (2014)
Global Radiation Therapy Equipment Market Revenue by Region (2010/2015E)
Volume of Radiation Therapy Equipment (LINAC's) by Country (2014)
Share of Cancer Patients Treated with Radiation Therapy by Region (2014)
Proton Therapy Application on the Basis of Cancer Site
Proton Therapy V/s X-Ray / IMRT - Prostate cancer
Proton Therapy Treatment Devices
Global Proton Therapy Market by Value (2013-2030)
Global Proton Therapy Market Value by Segment (2014-2030)
Global Proton Therapy Market by Annual Patient Volume (2006-2014)
Global Proton Therapy Market by Cumulative Patient Volume (2005-2014)
Global Proton Therapy Market by Patient Volume Forecast (2015-2030)
Global Proton Therapy Market by New Treatment Rooms (2006-2014)
Global Proton Therapy Market by Cumulative Treatment Rooms (2006-2014)
Global Proton Therapy Market by Cumulative Treatment Rooms Forecast (2015-2030)
Proton Therapy Cost per Room (2014-2019E)
Global Proton Therapy Market by Cumulative Proton therapy Centers (2006-2014)
Global Proton Therapy Market: Clinical Studies (2015E)
Global Proton Therapy Publications (1961-2015E)
Proton Therapy Patients Treatment Cumulative Volume, North America (2009/2014)
Proton Therapy Patients Treatment Cumulative Volume, Europe (2009/2014)
Proton Therapy Patients Treatment Cumulative Volume, Asia (2009/2014)
Proton Therapy Rooms, North America (2010/2014)
Proton Therapy Rooms, Europe and Russia (2010/2014)
Proton Therapy Rooms, Asia (2010/2014)
Number of Proton Beam Accelerator Centers, US (2009-2016E)
Global Cancer Incidences (2009-2019E)
The US Cancer Statistics by Cancer Site (2015E)
Comparison: New Cancer Cases to Cancer Deaths (2015E)
The US Non Invasive Cosmetic Procedures (2014)
Global Ageing Population (2009-2014)
Global Proton Therapy Share by Center Sales (2014)
Global Proton Therapy Share by Room Sales (2014)
Global Proton Therapy Share by System Sales (Jan 2015 - July 2015)
Global Proton Therapy Share by Room Sales (Jan 2015 - July 2015)
Varian Medical Systems' Revenue Share by Business Segments (2014/2015)
Varian Medical Systems' Revenue Share by Region (2013-2015)
Varian Medical Systems Revenue Share by Sales (2013-2015)
Varian Medical Systems Revenues and Net Earnings (2011-2015)
Elekta's Revenue by Geographical Segments (2013-14/2014-15)
Elekta Net Revenues (2010-11 to 2014-15)
IBA Revenue Share by Business Segments (2014)
IBA Sales (2010-2014)
IBA Net Sales by Segments (2010-2014)
Hitachi Ltd. Revenue Share by Business Segments (2014/2015)
Hitachi Ltd. Revenue and Net Income (2012-2014)

List of Tables

Cancer Prevalence Statistics in the US (2014/2015)
Cancer Incidents and Radiation Units in LMIC Region (2013)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Are UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs and clearing the way for an influx of biosimilars; ...

Hepatitis C: Kol Insight

September 2016 $ 8085

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.